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INTRODUCTION 
Obesity is now reported in epidemic proportions internationally, with many countries such as 
the United States, Mexico, Australia and New Zealand now reporting between a quarter and a 
third of their population as being obese[1]. As such, obesity and obesity-related chronic 
diseases are fast becoming the most significant health problems faced globally. 
 
Obesity is responsible for a significant proportion of healthcare related costs. In Australia, 
AU$ 2 billion was attributed to obesity related health care costs in 2008, accounting for 
approximately 25% of the direct and indirect costs associated with obesity[2]. Similarly the 
annual costs associated with obesity in the United States and the United Kingdom 
respectively are estimated to exceed US$ 50 billion and GB£ 2 billion[3,4]. 
 
In this context, both effective population-based prevention strategies along with sustainable 
individual management approaches are being urgently sought to reduce the burden of disease 
and economic demands caused by widespread obesity. Bariatric surgical procedures, such as 
laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic vertical sleeve 
gastrectomy (LVSG), are increasingly being recommended as cost-effective and efficacious 
strategies to manage obesity related chronic disease and metabolic conditions in the 
moderately to severely obese individuals[1,5-7]. LRYGB is a two step procedure in which 
the gastric reservoir is significantly reduced and proximal intestine bypassed to induce a level 
of malabsorption to further facilitate weight loss[2,8]. Moreover changes in gastric hormone 
signaling (such as peptide YY and glucagon like factor -1) may further reduce appetite and 
modulate energy expenditure therefore maintaining weight loss over long period of time[9]. 
LVSG, on the other hand, is a purely restrictive procedure involving the permanent removal 
of 90% of the stomach volume while maintaining the integrity of the pyloric sphincter. 
However, as with all surgical procedures - particularly those in a high-risk bariatric 
population - these procedures are not without a degree of risk of complications that may lead 
to further burden on the health system and diminished postoperative quality of life. These 
complications may be related to surgical skills, surgical techniques, obesity, maladaptive 
physiological responses to the procedure, change in anatomy and malabsorption to name but 
a few[10,11]  
 
This aim of this systematic review and meta-analysis is to study the peer review literature 
regarding late postoperative complications reported from randomised control trials (RCTs) 
comparing LVSG and LRYGB bariatric procedures. 
 
MATERIALS AND METHODS 
Inclusion and Exclusion Criteria 
RCTs comparing clinical outcomes of LVSG and LRYGB procedures were reviewed. 
Additional inclusion criteria included adult subjects (>18 years), elective surgical patients 
randomised to receive either LVSG or LRYGB, and clinically relevant outcomes reported 
pertaining to late complications (occurring >30-days postoperatively). These included 
mortality, major and minor complications, and interventions and/or hospital readmissions 
required for their management. Qualitative review was performed on all studies that met 
inclusion criteria, and meta-analyses were run on outcome variables where numbers and 
methods of reporting were sufficient to allow statistical analysis.  
 
Search Strategies and Data Collection 
Electronic databases (Medline, Pubmed, EMBASE, CINAHL, Cochrane Register of 
Systematic Reviews, Science Citation Index) were cross-searched for RCTs published 
between 2000 and November 2015 to capture the studies since Regan et al’s[12] description 
of the LVSG as a stand-alone procedure, using search terms optimised for each search engine 
in an attempt to identify all published papers meeting the inclusion criteria. Limits were set to 
RCTs and adult patients (>18yrs) to reflect the inclusion criteria. Search strategies utilized 
included combinations of "laparoscopy"[MeSH Terms] OR "laparoscopy"[All Fields] OR 
"laparoscopic"[All Fields]), "gastric sleeve"[All Fields] OR "sleeve gastrectomy"[All Fields] 
AND "roux en y"[All Fields] OR "*gastric bypass"[All Fields] AND "outcomes"[All Fields]. 
Reference lists of existing review articles were examined for additional citations. Authors of 
included papers were contacted by e-mail for clarification or additional information where 
required.  
 
The Preferred Reporting of Systematic Reviews and Meta-Analyses (PRISMA) statement 
was adopted. Two authors (EO and MAM) independently appraised identified studies to 
confirm compliance with agreed inclusion criteria. One author (EO) undertook the data 
extraction. The authors were not blinded to the source of the document or authorship for the 
purpose of data extraction. The data were compared and consensus was achieved through 
discussion or contact with corresponding authors when required.  
 
The methodological quality of identified studies was assessed using the Jadad scoring 
system[13]. This method produces a number between one and five based on the reporting of 
randomization, blinding and accounting for all subjects at the end of the follow up period, 
with higher scores representing a higher methodological quality[13]. 
Statistical Analysis 
Meta-analyses were performed using odds ratios (ORs) for binary outcomes and weighted 
mean differences (WMDs) for continuous outcome measures. An amended estimator of OR 
was used to avoid the computation of reciprocal of zeros among observed values in the 
calculation of the original OR[14]. Random effects model (REM), developed by 
DerSimonian and Laird[15] using the inverse variance weighted method approach and the 
inverse variance heterogeneity (IVhet) model developed by Doi et al[16] were used to 
combine the data to estimate the common effect size of the outcome variables. Heterogeneity 
among the effect size measures was assessed using the Q statistic[17,18] and I2 index[19,20]. 
Funnel plots were synthesized in order to assess for the presence of publication bias in the 
meta-analysis. Standard error was plotted against the treatment effects (Log OR for the 
dichotomous and WMD for continuous variables respectively)[21,22] to allow 95% 
confidence interval limits to be displayed. Estimates were obtained using computer programs 
written in R package for the random effects model, while the MetaXL program was used for 
computations under the inverse variance heterogeneity model referred to the paper[16,23]. 
All forest plots are for the estimates of the effect size obtained from the random effects model 
and were obtained using the ‘rmetafor’ package[24]. A significance level of 5% ( =0.05) 




Search outcomes revealed 478 citations identified through literature searches (k=473) and 
hand searches of bibliographical information (k=5). After removal of duplicates and 
screening of abstracts, 55 full text articles were retrieved and assessed against eligibility 

criteria. Of the 49 studies excluded, 39 were found not to be in conformity with RCT study 
design, 11 were reviews (including existing systematic reviews or meta-analyses), four 
studies reported different outcomes or follow up time frames of otherwise eligible studies, 
one did not report on clinical outcomes, one described outcomes of bariatric procedures in an 
adolescent population, one reported clinical outcomes of LVSG versus open LRYGB, while 
another reported LVSG versus mini gastric bypass. In addition, two protocols describing 
studies eligible for inclusion in this meta-analysis that currently in progress were also 
located[25,26]. Ultimately six studies[27-32] reported on a variety of late postoperative 
complication outcomes, and therefore were included for systematic review and meta-analysis 
as reported data allowed. See PRISMA diagram Figure 1. 
 
Six RCTs involving a total of 695 patients (LVSG n=347, LRYGB n=348) reported late 
complications with sufficient information for analysis. LVSG was compared with LRYGB in 
six studies[27-32]. Included studies were of a moderate methodological quality, with an 
average Jadad score of 3 (range 2 to 5). All studies reported randomization and accounted for 
all patients throughout the follow up period, while blinding was reported to have occurred in 
only one study[27]. All included studies were published within the last five years reporting 
on studies conducted between 2005 and 2015. Follow-up periods reported ranged from three 
months to three years postoperatively, with 32% to 100% follow up completed at the 
completion of the follow up period. Late complications are defined those occurring after 30-
days postoperatively. Table 1 outlines the characteristics of included studies.  
 
Mortality 
No study reported deaths occurring in the late postoperative period. 
Late Major Complications 
All six included RCTs representing 685 patients (LVSG n=345; LRYGS n=340) reported 
major complications occurring in the late postoperative period[27,28,31,32]: this was either 
implied within the paper or confirmed by correspondence with the authors. The 
categorization as to what constituted a major complication varied between studies: these 
included the Clavien-Dindo classification system for severity of complications[28], a specific 
set outcomes (death or reoperation, LOS beyond postoperative day seven, or the need for four 
or more blood transfusions) [31,32], bleeding[30], while two studies did not describe how 
complications were classified[27,29]. 
 
Major complications occurring in the late postoperative period are described in Table 2. 
Different patterns of complications were reported between LVSG and LRYGB, with fewer 
late complications being reported following the LVSG procedure than LRYGB (n=4 across 
k=3 versus n=8 across k=4 respectively).  
 
A reduction in relative odds favoring the LVSG procedure was observed, however this did 
not reach statistical significance (OR 0.64; 95% CI 0.21, 1.97; p=0.4). No significant 
heterogeneity was observed in pooled results (Q=1.57, p=0.9; I2 =0%, 0-47.2%). See Figure 
2. REM and IVhet models provided equivocal results. 
 
Late Minor Complications 
Four RCTs representing 408 patients (LVSG n=208, LRYGB n=200) reported late minor 
complications, either expressed or implied in the text. Classification of minor complications 
varied from default classification if conditions for ‘major complication’ were not met[30-32], 
or no description provided[29]. 
 
Various late minor complications were reported, with a higher number reported in those 
having received LRYGB compared to LVSG (n=17 vs n=10 respectively). 
Dumping and pneumonia were reported to occur in both procedures. See Table 3. Helmiö et 
al[31] reported proportionally higher incidents of late minor complications than the other 
studies reporting on this outcome. 
 
A non-statically significant reduction in relative odds of 36% favoring the LVSG procedure 
was observed (OR=0.64; 95% CI 0.28, 1.47; p=0.3) when the REM was applied. No 
heterogeneity was observed in pooled results (Q=2.92 p=0.4; I2 =0%, 0-95%) using the REM. 
See Figure 3. The IVhet model provided equivocal results to the REM. 
 
Interventions and Readmissions Required for the Management of Late Complications 
Reoperations and any other type of intervention required for the management of late 
complications and any hospital readmissions were extrapolated from the published papers, 
and where necessary, was confirmed with the corresponding authors. As such all six included 
papers (LVSG n=345; LRYGB n=340) contributed data for analysis.  
 
Table 4 describes the required procedures by surgical type. Interventions for the management 
of late complications appeared to be required more frequently following LRYGB than LVSG 
(n=6 over k=4, compared to n=3 over k=4 respectively).  
 
A 37% relative reduction in odds was observed in favor of the LVSG for the need for 
additional interventions to manage late postoperative complications, however this did not 
reach statistical significance (OR 0.63; 95% CI 0.19, 2.05; p=0.4). Figure 4. No heterogeneity 
in pooled data was detected (Q=1.7, p=0.9; I2=0%, 0-49.3%). REM and IVhet models 
provided equivocal results. 
 
No study specifically reported readmissions required for the management of late 
complication. One study reported all complications were able to managed with medication 




Funnel plots do not suggest the presence of publication bias as evidenced by all points 
remaining within the 95% CI limits in plots of Log OR against standard error. 
 
DISCUSSION 
Complications after many complex bariatric surgical procedures vary widely across hospitals 
and surgeons. For a valuable quality assessment, relevant data on complications must be 
obtained in a standardized and reproducible manner to allow comparison for a particular 
procedure among different centers and amongst different surgeon within a center over time. 
The absence of consensus within the surgical community on the best way to report surgical 
complications has hampered proper evaluation of the surgeon’s work and possibly progress 
in the surgical field[10,11].This systematic review and meta-analysis was conducted to 
compare late complications for two different types of bariatric procedures, namely, LVSG 
and LRYGB. Our meta-analysis of six RCTs suggests that when considered in terms of the 
development of late complications, LVSG and LRYGB provide comparable outcomes. No 
statistically significant differences were observed in point estimates of the parameters that 
were included for meta-analysis, and outcomes appeared to be comparable between 
intervention groups within studies when compared qualitatively.  
 
Although a number of reviews on this topic exist in the peer review literature, this is the first 
systematic review and meta-analysis to specifically review the development of late 
complications in LVSG versus LRYGB bariatric procedures. These are important 
considerations, given that both these procedures are irreversible and that many of the late 
complications reported (such as the development of strictures, bowel obstructions secondary 
to adhesions, and severe dumping syndrome) may pose significant malnutrition risks when 
patients remain symptomatic for extended periods. As such it is possible that though obesity 
and obesity-related comorbidities may be managed by bariatric procedures, late 
complications have the potential to give rise to a new set of malnutrition-related chronic 
health problems as a direct consequence of the bariatric procedure. However, the results of 
this review indicate that late complications reported between six months and three years 
postoperatively are equivocal between procedures. It should be noted that this time frame 
may not be sufficient to provide a clear indication of the prevalence or severity of 
complications arising in the later postoperative period. This is a concern as only two 
studies[29,32] reporting on 64 patients in each (18% of all participants represented in this 
review) were followed to three years postoperatively. Studies that specifically monitor the 
development of late complications beyond the initial years postoperatively are limited in the 
literature at the present time, while those specifically examining late complications that give 
rise to new chronic health problems are altogether lacking. 
 
In addition to posing a more specific clinical question, the current review differs from those 
that already exist in the literature in a number of ways. Firstly, the present work has limited 
its inclusion to RCTs in an attempt to ensure the studies included are of sufficient 
methodological robustness and homogeneity to strengthen the conclusions drawn from 
combining them into a systematic review and meta-analysis. This is a significant point of 
difference from the recent systematic reviews and/or meta-analyses by Li et al, Yang et al 
and Zhang et al, who include a high number of uncontrolled studies included in their 
analyses[33-35]. By including only RCTs of laparoscopic LVSG and LRYGB procedures in 
the current work, we have strengthened the conclusions and applicability to practice by 
reducing potential bias and heterogeneity of the included studies. This has resulted in the 
additional benefit of describing a comparable number of patients receiving each procedure in 
the current work: This is uncommon in reviews of this topic, yet important for an impartial 
interpretation of outcomes. Furthermore the current work has been conducted using the 
PRISMA guidelines to ensure transparency in reporting. Importantly, it also includes several 
recently published RCTs that were not available for inclusion in previously reviews of this 
topic, several of which are well powered to demonstrate a clinical difference between 
procedures [28,31]. 
 
Finally, a further strength of this meta-analysis is that it has adopted the IVhet model recently 
described by Doi et al[16], in addition to the currently accepted REM. The IVhet model 
offers the advantage of being a distributional assumption free model of meta-analysis, thus 
overcoming the unjustified assumption of normally distributed random effects in the setting 
of meta-analysis[16]. Estimates obtained from the IVhet model offer a number of advantages 
over those obtained from the REM: (1) larger trials (with greater statistical power to 
demonstrate benefit/harm and less variance) are apportioned greater influence than smaller 
studies on the final point estimates, (2) produces more conservative point estimates and 
confidence intervals, which provide a measure of protection against spurious measures of 
statistical significance, and (3) reduces true variance independent of present 
heterogeneity[16]. These advantages take on increased significance when considered in light 
of the way the results of meta-analyses have the potential to alter clinical practice and to 
justify large research trials. Re-analysis of existing meta-analyses in the literature with 
models of meta-analysis that produce more conservative estimates than the REM have 
demonstrated the potential impact the use of different models may have on the results 
obtained and the subsequent conclusions drawn [36,37]. As these differences pose potential 
clinical and cost implications, an issue of considerable importance for the application of 
evidence-based practice. Clinical decision makers therefore have an obligation to ensure any 
changes to practice generated from the findings of meta-analyses are supported by the most 
robust statistical methods available to ensure safe and cost effective practice is maintained. 
The use of the IVhet model of meta-analysis therefore strengthens the conclusions drawn 
from it, and provides a further point of difference from other reviews on this topic. 
 
LIMITATIONS 
There are also a number of potential factors that may influence or confound the results of our 
systematic review and meta-analysis. First, we have focused complications occurring >30-
days postoperatively following LRYGB and LVSG, however the methods of categorizing 
and describing complications vary between studies included. All studies reported major 
complications, however reporting of these ranged from an established classification system to 
no description at all. Minor complications were less routinely reported, and generally 
attributed to any complications that did not meet the conditions for being reported as a major 
complication. Late complications were generally less clearly defined than were early 
complications. Ultimately without consistent definitions being used to describe complications 
it is difficult to know if appropriate comparisons are being made between studies. 
 
Second, in complicated bariatric procedures the technical skill of the operating surgeon is 
recognized to be an important factor contributing to both perioperative and postoperative 
complication rates. In a study investigating the relationship between surgical skill and 
complication rates after bariatric surgery, Birkmeyer et al[11] demonstrated that surgeons in 
the top quartile of skill ratings compared with those in the lowest quartile of skill rating had 
shorter operating times, fewer overall complications (5.2% vs 14.5%), lower rates of 
reoperation, 30-day readmission and emergency department presentations, and less 
postoperative mortality. Surgical skill was strongly correlated with procedure volume, 
however other factors such as years of bariatric surgical practice, completion of a fellowship 
in laparoscopic or bariatric surgery, or practice location did not appear to influence skill 
ratings[11]. In view of the apparent role of technical surgical skill in the development of 
postoperative outcomes, it is inappropriate to fully attribute the outcomes reported solely to 
the procedures themselves, as the experience of the surgeons involved remains unknown and 
unreported within the included studies. The role of surgical technique rather than skill is more 
important on the development of late complications such as anastomotic problems and bowel 
obstruction which occur over the surgical site. This could be complicated further by the 
choice of mechanical devices (i.e staplers) which may malfunction or fail.  The link to 
surgical skill may be less obvious in the case of other complications that do not occur at the 
surgical site[11]. 
 
Third is the potential impact of the moderate methodological quality of the included studies. 
Of the six included studies, only one obtained a score of greater than three (of the possible 
five) according to the Jadad score[27], and this can be accounted for by the lack of blinding 
in the remaining studies. This is a recognized limitation of established scores to assess 
traditional measures of methodological quality, which are difficult to apply to surgical studies 
where blinding of interventions are often not possible or ethical. The usefulness of 
methodological assessments within meta-analysis remains a source of debate, and 
recommendations to individually assess studies against predetermined methodological 
qualities relevant to the given study context are gaining favor[38]. When considered in this 
light, the methodological quality of the included papers may perform better than their Jadad 
score implies. 
 
Finally there remain a relatively small number of RCTs investigating this topic, which is a 
limitation to the statistical power of the analyses performed. 
 
CONCLUSIONS 
In conclusion, this systematic review and meta-analysis of RCTs suggests that the 
development of late complications is similar between LVSG and LRYGB procedures, six 
months to three years postoperatively. Due to the limited reporting after this time period 
conclusions about late complications developing beyond three years postoperative period 
cannot be made at this time. This highlights the need for longer-term surveillance of patients 
post bariatric procedures so as to more accurately describe the patterns of late complications 
that occur in this population, and to therefore inform surgical procedure selection appropriate 
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Table 1 – Characteristics of included studies 
Authors / Year / 
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group (% follow up 












Inclusions Exclusions Primary outcome 
LVSG LRYGB BMI Age 
(years) 
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Helmio et al 
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2012 / Finland31 
Prospective RCT 
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Kehagias et al / 
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?4/5 (2/ 
1or 2/ 1) not stated 
not 
stated not stated not stated weight loss 
Zhang et al / 2014 
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GI surgery weight loss 
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de Barros et al / 
2015 / Brazil30 
Prospective RCT 
























glycaemic control at 90 
days 
 
R= Randomisation, B=blinding=withdrawals, ED= eating disorder, GI=Gastrointestinal, BMI=Body Mass Index; mth=month; 
yrs=years 
  











Incarcerated incisional hernia31 
Obstruction due to adhesions27 







Table 3: Late minor complications reported in included studies 
Minor complications 
LVSG LRYGB 
Infection (intra-abdominal or 
unknown source) 31 
Pneumonia31 
Reflux oesophagitis31, 32 
Stricture at GEJ31 
Ketoacidosis31 
Persistent difficulties eating31 
Dumping31 
Dumping31, 32  
Pneumonia31 
Ulcer at Gastro-jejunal 
anastomosis31 









Table 4: Reoperation or endoscopic procedures following complications 
RCT Procedures Complications Reoperation or Endoscopic procedures 
Helmio et al 201231 LRYGB 
 
incarcerated incisional hernia Relaparoscopy 
Kehagias et al 201127 LRYGB 
 
LVSG 
leakage at cardio-oesophageal junction 
 
management of abdominal abscess 
 IV antibiotics and drainage 
 
CT guided percutaneous drainage and 
antibiotics 












Conversion to LRYGB 
 
Endoscopic dilatation 
 
